Acasti Pharma Inc.
ACST
Peringkat dalam Saham
#29735
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Harga Saham
$0.4256834
Terakhir disinkronkan: 2023-03-27
Kapitalisasi Pasar
$18.99M
Perubahan (1 hari)
3.08%
Perubahan (1 tahun)
-87.02%
Negara
CA
Perdagangan Acasti Pharma Inc. (ACST)
Kategori
Healthcare
EPS untuk Acasti Pharma Inc. (ACST)
EPS per June 2026 TTM: $-1.17
Menurut laporan keuangan terbaru dan harga saham Acasti Pharma Inc., EPS perusahaan saat ini (TTM) adalah $-1.17. Pada akhir 2024, perusahaan memiliki EPS sebesar $-1.35 penurunan dibandingkan dengan EPS tahun 2023 sebesar $-5.71.
Riwayat EPS untuk Acasti Pharma Inc. dari 2010 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $-1.17 | 48.10% |
| 2025 | $-0.79 | -41.48% |
| 2024 | $-1.35 | -76.36% |
| 2023 | $-5.71 | 256.88% |
| 2022 | $-1.60 | -79.90% |
| 2021 | $-7.96 | -5.01% |
| 2020 | $-8.38 | 73.17% |
| 2019 | $-4.84 | -19.49% |
| 2018 | $-6.01 | -61.25% |
| 2016 | $-15.51 | 224.41% |
| 2015 | $-4.78 | -91.08% |
| 2014 | $-53.58 | 24.03% |
| 2013 | $-43.20 | -8.51% |
| 2012 | $-47.22 | 102.66% |
| 2011 | $-23.30 | -26.64% |
| 2010 | $-31.76 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| $17.32 | -1,580.34% |
US
|
|
| $-7.98 | 582.05% |
US
|
|
| $-5.29 | 352.14% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,470.94% |
NL
|
